|
Tuesday 23 August 2005
Strangling tumours in bid to halt cancer
It may be possible to halt cancer in its tracks by
blocking a gene critical to building tumour supply lines, according to new
research carried out at the University of Queensland.
Most tumours need a blood supply to grow.
Researchers at the Institute for Molecular Bioscience
have found that when new blood vessels form – in developing embryos and in
tumours – a gene, known as Sox18, switches on for just 48 hours.
“In adult mice, we have found that interfering with this
gene reduces tumour growth by up to 80 percent,” says postdoctoral scientist Dr
Neville Young. “A surprisingly large number of people carry microscopic tumours
inside their bodies but these cells never develop into disease.
“One of the reasons these cancerous cells do not rage out
of control is that they never establish a blood supply to feed them. Those
unlucky enough to develop malignant tumours often do so when cancerous cells
co-opt the body’s own blood supply.”
Sox18 has an important role to play in helping
specialised cells travel to the right position and then form the tubes needed
for blood flow.
Dr Young says that targeting blood vessels was not a new
concept in the fight against cancer, but that one of the big problems was the
side effects of current treatments.
“The novel thing about targeting Sox18 is that it is only
turned on in new blood vessels feeding the growing tumour,” he says. “It does
not seem to affect any other blood vessels in the body. By attacking only Sox18
we might be able to stop these new vessels forming while leaving the rest of the
blood supply alone.”
The next step is to test whether researchers can
manufacture a drug for humans that can mimic the observed effects in mice. They
also need to design a delivery system to get the drug to the growing blood
vessel cells to switch Sox18 off.
The early stages of this research are already underway
with preliminary results expected within two years. This is dependent on ongoing
funding for this research.
Neville is one of 13 Fresh Scientists who are presenting
their research to the public for the first time thanks to Fresh Science, a
national program sponsored by the Federal and Victorian Governments.
One of the Fresh Scientists will win a trip to the UK courtesy of the British Council to
present his or her work to the Royal Institution.
|